Advertisement

Differentiation of Substance P and Physalaemin

  • F. Geipert
  • F. Lembeck
  • B. Sprössler
Chapter

Summary

  1. 1

    The physical and chemical properties of substance P (extracted from bovine brain) and physalaemin were investigated by several methods.

     
  2. 2

    During paper electrophoresis at pH 4.95 substance P migrates towards the cathode, physalaemin remains at the starting point.

     
  3. 3

    During carrier-free glucose gradient electrophoresis substance P moves to the cathode whereas physalaemin remains at the starting point.

     
  4. 4

    Electrofocusing of physalaemin reveals an isoelectric point of pH 7.0 whereas substance P has an isoelectric point of pH 10.0 to 10.5.

     
  5. 5

    The biological activity of physalaemin was reduced by 70% after treatment with diazotized p-nitraniline, but that of substance P and eledoisin was not reduced. All three peptides were inactivated by treatment with phenylisocyanate. It was concluded therefore, that phenolic hydroxyl groups are not essential for the biological activity of substance P.

     

Key-Words

Substance P Physalaemin Eledoisin Gradient Electrophoresis Electrofocusing Inactivation Procedures 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ambache, N.: Further studies on the preparation, purification and nature of irin. J. Physiol. (Lond.) 146, 255 (1959).Google Scholar
  2. Bernardi, L.: Synthetic peptides related to physalaemin and eledoisin. In: Hypotensive peptides. Hrsg. E.G. Erdös, N. Back, F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  3. Bertaccini, G., Cei, J.M., Erspamer, V.: Occurence of physalaemin in extracts of the skin of physalaemus fuscumaculatus and its pharmacological actions on extravascular smooth muscle. Brit. J. Pharmacol. 25, 363 (1965).PubMedGoogle Scholar
  4. Boissonnas, R.A., Franz, J., Stürmer, E.: Chemical characterization of substance P. Ann. N.Y. Acad. Sci. 104, 376 (1963).PubMedCrossRefGoogle Scholar
  5. Ersparmer, V., Anastasi, A., Bertaccini, G., Cei, J.M.: Structure and pharmacological actions of physalaemin, the main active polypeptide of the skin of physalaemus fuscumaculatus. Experientia (Basel) 20, 489 (1964).CrossRefGoogle Scholar
  6. Groves, W.E., Davis, F.C., Jr., Sells, B.H.: Spectrophotometric determination of microgram quantities of protein without nucleic acid interference. Analyt. Biochem. 22, 195 (1968).PubMedCrossRefGoogle Scholar
  7. Knabe, u. H.: Ausbeute an Substanz P aus dem Hirn verschiedener Tierspezies bei Anwendung zweier Extraktionsverfahren. Inaug.-Diss., Eberh.-Karls-Univ., Tübingen 1968.Google Scholar
  8. Lembeck, F.: Über den Nachweis von 5-Oxytryptamin (Enteramin, Serotonin) in Carcinoidmetastasen. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 221, 50 (1954).CrossRefGoogle Scholar
  9. — Fischer, G.: Gekreuzte Tachyphylaxie von Peptiden. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 258, 452 (1967).CrossRefGoogle Scholar
  10. — Geipert, F., Starke, K.: Sialogene Wirkung von Peptiden bei Hühnern. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 261, 422 (1968a).CrossRefGoogle Scholar
  11. — Oberdorf, A., Starke, K., Hettich, R.: Sialogene und glattmuskuläre Wirkung von Physalämin-Derivaten und Substanz P. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 261, 338 (1968b).CrossRefGoogle Scholar
  12. — Starke, K.: Behandlung von Substanz P-Präparaten mit Aluminiumoxid. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 259, 307 (1968).CrossRefGoogle Scholar
  13. Lowry, O.H., Rosebrough, N.Y., Farr, A.L., Randall, R.J.: Protein measurement with the folin phenol reagent. J. biol. Chem. 193, 265 (1951).PubMedGoogle Scholar
  14. Meinardi, H., Craig, L. C: Studies on substance P. In: Hypotensive peptides. Hrsg. V. E.G. Erdös, N. Back, F. Sicuteri. Berinl-Heidelberg-NewYork: Springer 1966.Google Scholar
  15. Paton, D.M.: Effects of metabolic inhibitors on contraction of rabbit detrusor muscle. Brit. J. Pharmacol. 34, 493 (1968).CrossRefGoogle Scholar
  16. Starke, K., Lembeck, F., Lorenz, W., Weiss, U., Geipert, F.: Die Wirkung Substanz P-ähnlicher Peptide auf die Speichelsekretion. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 260, 204 (1968).CrossRefGoogle Scholar
  17. Vogler, K., Haefely, W., Hürlimann, A., Studer, R.O., Lergier, W., Strässle, R., Berneis, K.H.: New purification procedure and biological properties of substance P. Ann. N.Y. Acad. Sci. 104, 378 (1963).PubMedCrossRefGoogle Scholar
  18. Zetler, G.: Zwei neue pharmakologisch aktive Polypeptide in einem SP-haltigen Hirnextrakt. Naunyn-Schmiedebergs Arch. exp. Path. Pharmak. 242, 330 (1961).CrossRefGoogle Scholar
  19. — Baldauf, J.: Chromatographische Analyse eines Substanz P-Präparates aus Gehirn. Naunyn-Schmiedebergs Arch. Pharmak. exp. Path. 256, 86 (1967).CrossRefGoogle Scholar
  20. Zuber, H.: Purification of substance P. In: Hypotensive peptides. Hrsg. V. E.G. Erdös, N. Back, F. Sicuteri. Berlin-Heidelberg-New York: Springer 1966.Google Scholar
  21. — Jaques, R.: Isolierung von Substanz P aus Rinderhirn. Angew. Chem. 74, 216 (1962).CrossRefGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1969

Authors and Affiliations

  • F. Geipert
    • 1
  • F. Lembeck
    • 1
  • B. Sprössler
    • 2
  1. 1.Pharmakologisches InstitutUniversität A- 8010 GrazUniversitätsplatz 4Österreich
  2. 2.Institut für Mikrobiologie und MolekularbiologieUniversität Stuttgart-HohenheimDeutschland

Personalised recommendations